News & Insights

Biofourmis announced today that its Biofourmis Care solution has been selected by the American College of Cardiology (ACC) for its TRANSFORM(3) study

Our experienced panel discusses how leading healthcare systems are using virtual care-at-home to improve operational excellence and improve patient outcomes & satisfaction by expanding the population of patients who can be monitored, managed, and treated in the comfort of their own homes.

What has pharma actually achieved? Identify the greatest areas of investment and review where ROI can best be demonstrated and increased going forward

Until recently, acute care technological innovations were centered on improvements in procedural interventions or critical care. Accelerated by the pandemic, there has been a shift and developing interest in bringing acute-level care into the home. As a result, more tech-enabled improvements are supporting decentralized care models. Developments in artificial intelligence (AI) and machine learning (ML), combined with clinical necessity, are enabling healthcare systems to deliver better care beyond the four walls of the hospital.

Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, today announced that it was selected by Blessing Health System in Quincy, Ill., as the technology solutions partner for its newest program, which delivers acute-level hospital care inside patients’ homes.